Skip to main content
. Author manuscript; available in PMC: 2023 Nov 5.
Published in final edited form as: Neurocrit Care. 2014 Oct;21(2):228–237. doi: 10.1007/s12028-013-9951-x

Table 3.

The different types of adverse drug events experienced by subjects taking phenytoin and levetiracetam who did not have missing electronic health record information, and the incidence proportions of subjects who experienced each type of event

Adverse drug effect Phenytoin arm (n = 122) Levetiracetam arm (n = 164)

Decreased level of consciousness 5 (4.1) 0 (0.0)
Liver dysfunction 4 (3.3) 1 (0.6)
Rash 4 (3.3) 0 (0.0)
Persistent fevers 3 (2.5) 0 (0.0)
Neutropenia 1 (0.8) 0 (0.0)
Vertigo 2 (1.6) 0 (0.0)
Drug switch 7 (5.7) 1 (0.6)
Cognitive problems 0 (0.0) 0 (0.0)
Fatigue 0 (0.0) 1 (0.6)
Vomiting 0 (0.0) 1 (0.6)
Decreased appetite 0 (0.0) 1 (0.6)
Death 0 (0.0) 1 (0.6)
Total 26 (21.3) 6 (3.7)